# Preoperative Olaparib Endometrial Carcinoma Study (POLEN)

> **NCT02506816** · — · COMPLETED · sponsor: **MedSIR** · enrollment: 36 (actual)

## Conditions studied

- Endometrial Carcinoma

## Interventions

- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT02506816
- **Lead sponsor:** MedSIR
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-07
- **Final completion:** 2019-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-11-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506816, "Preoperative Olaparib Endometrial Carcinoma Study (POLEN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02506816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*